Terms: = Uterine cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Prognosis
11 results:
1. A novel necroptosis-associated miRNA signature predicting prognosis of endometrial cancer and correlated with immune infiltration.
Ye Z; Jiang Y; Wu J
Taiwan J Obstet Gynecol; 2023 Mar; 62(2):291-298. PubMed ID: 36965898
[TBL] [Abstract] [Full Text] [Related]
2. Cervical cancer survival times in Africa.
Drokow EK; Fangninou FF; Effah CY; Agboyibor C; Zhang Y; Arboh F; Deku MA; Xinyin W; Wang Y; Sun K
Front Public Health; 2022; 10():981383. PubMed ID: 36438301
[TBL] [Abstract] [Full Text] [Related]
3. A novel lncRNA-mRNA-miRNA signature predicts recurrence and disease-free survival in cervical cancer.
Li M; Tian X; Guo H; Xu X; Liu Y; Hao X; Fei H
Braz J Med Biol Res; 2021; 54(11):e11592. PubMed ID: 34550275
[TBL] [Abstract] [Full Text] [Related]
4. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical cancer: A Bioinformatics Analysis.
Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
[TBL] [Abstract] [Full Text] [Related]
5. Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer.
Scholl SM; Beal J; de Koning L; Girard E; Popovic M; de la Rochefordière A; Lecuru F; Fourchotte V; Ngo C; Floquet A; Berns EM; Kenter G; Gestraud P; von der Leyen H; Lecerf C; Puard V; Roman SR; Latouche A; Kereszt A; Balint B; Rouzier R; Kamal M
EBioMedicine; 2020 Nov; 61():103049. PubMed ID: 33096476
[TBL] [Abstract] [Full Text] [Related]
6. Comparative study on the oncological prognosis of laparoscopy and laparotomy for stage IIA1 cervical squamous cell carcinoma.
Chen C; Fang Z; Wang Q; Li W; Li P; Wang L; Kang S; Zhu B; Lin Z; Wang X; Wang L; Fan H; Bin X; Lang J; Liu P
Eur J Surg Oncol; 2021 Feb; 47(2):346-352. PubMed ID: 32859433
[TBL] [Abstract] [Full Text] [Related]
7. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
[TBL] [Abstract] [Full Text] [Related]
8. The incidence and predictors of gynecologic malignancies among postmenopausal patients with endometrial fluid collection.
Li Z; Li L
Arch Gynecol Obstet; 2019 Apr; 299(4):1071-1076. PubMed ID: 30519752
[TBL] [Abstract] [Full Text] [Related]
9. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma.
Tsuyoshi H; Yoshida Y
Cancer Sci; 2018 Jun; 109(6):1743-1752. PubMed ID: 29660202
[TBL] [Abstract] [Full Text] [Related]
10. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract] [Full Text] [Related]
11. Clinicopathologic analysis of the prognostic factors in women with coexistence of endometrioid adenocarcinoma in the endometrium and ovary.
Nishimura N; Hachisuga T; Yokoyama M; Iwasaka T; Kawarabayashi T
J Obstet Gynaecol Res; 2005 Apr; 31(2):120-6. PubMed ID: 15771637
[TBL] [Abstract] [Full Text] [Related]
